When DOX was loaded into these complexes, Syp-1-liposomes-DOX exhibited remarkable antitumor efficiency in the inhibition of tumor growth compared with LyP-1-liposomes-DOX (Li et al., 2013). Here, PTPN22 is linked to neoplasm.